3D PRINTED HAIR FOLLICLES: A PIONEERING ACHIEVEMENT November 17, 2023 3D PRINTED HAIR FOLLICLES: A PIONEERING ACHIEVEMENT Read More »
LIMONIN: A PROMISING NATURAL REMEDY FOR HAIR LOSS November 15, 2023 LIMONIN: A PROMISING NATURAL REMEDY FOR HAIR LOSS Read More »
FOLLICULAR MINIATURIZATION AND ANDROGEN SENSITIVITY November 15, 2023 FOLLICULAR MINIATURIZATION AND ANDROGEN SENSITIVITY Read More »
MINOXIDIL SHORTAGE MAY IMPACT PATIENT HAIR GROWTH November 5, 2023 MINOXIDIL SHORTAGE MAY IMPACT PATIENT HAIR GROWTH Read More »
HMI-115 MANUFACTURING FOR BALDNESS MAY BE SPED UP November 1, 2023 HMI-115 MANUFACTURING FOR BALDNESS MAY BE SPED UP Read More »
SCUBE3 AND OSTEOPONTIN: THE DYNAMIC DUO FOR HAIR LOSS PREVENTION October 21, 2023 SCUBE3 AND OSTEOPONTIN: THE DYNAMIC DUO FOR HAIR LOSS PREVENTION Read More »
GT20029 PERFORMS WELL IN PHASE 1 TRIALS FOR ANDROGENETIC ALOPECIA October 20, 2023 GT20029 PERFORMS WELL IN PHASE 1 TRIALS FOR ANDROGENETIC ALOPECIA Read More »
HMI 115 FROM HOPE MEDICINE IS CLEARED FOR PHASE II TRIALS October 20, 2023 HMI 115 FROM HOPE MEDICINE IS CLEARED FOR PHASE II TRIALS Read More »
EXOGENOUS HUMAN GROWTH HORMONE (HGH) FOR HAIR LOSS October 14, 2023 EXOGENOUS HUMAN GROWTH HORMONE (HGH) FOR HAIR LOSS Read More »
ORAL AND TOPICAL FINASTERIDE EFFICACY FOR HAIR LOSS October 14, 2023 ORAL AND TOPICAL FINASTERIDE EFFICACY FOR HAIR LOSS Read More »
USING WAY-316606 TO UNLOCK HAIR GROWTH POTENTIAL October 14, 2023 USING WAY-316606 TO UNLOCK HAIR GROWTH POTENTIAL Read More »
JAK INHIBITORS AND THEIR PROMISING ROLE IN HAIR LOSS October 13, 2023 JAK INHIBITORS AND THEIR PROMISING ROLE IN HAIR LOSS Read More »
FINASTERIDE OR DUTASTERIDE: WHICH IS BETTER FOR HAIR LOSS? October 13, 2023 FINASTERIDE OR DUTASTERIDE: WHICH IS BETTER FOR HAIR LOSS? Read More »
IS REDENSYL THE BREAKTHROUGH SOLUTION FOR HAIR LOSS? October 13, 2023 IS REDENSYL THE BREAKTHROUGH SOLUTION FOR HAIR LOSS? Read More »
THE ROLE OF MIRCORNA (miR-205) IN HAIR LOSS CURES October 11, 2023 THE ROLE OF MIRCORNA (miR-205) IN HAIR LOSS CURES Read More »